Comparison of serum levels of seven cytokines in premature newborns undergoing different ventilatory procedures: High frequence oscillatory ventilation or synchronized intermittent mandatory ventilation

European Cytokine Network

Volumn 16, Issue 3, 2005, Pages 199-205

  Capoluongo, Ettore ^a   Vento, Giovanni ^a   Santonocito, Concetta ^a   Matassa, Piero Giuseppe ^a   Vaccarella, Cinzia ^b   Giardina, Bruno ^a   Romagnoli, Costantino ^a   Zuppi, Cecilia ^a   Ameglio, Franco ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

IL 10; IL 6; IL 8; Premature newborns; Serum; Ventilatory procedures

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; CYTOKINE;

ARTICLE; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAS EXCHANGE; HIGH FREQUENCY OSCILLATION; HIGH FREQUENCY VENTILATION; HUMAN; INFANT; INTERMETHOD COMPARISON; INTERMITTENT MANDATORY VENTILATION; MALE; NEWBORN MONITORING; PREMATURITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; BLOOD; CHRONIC DISEASE; COMPARATIVE STUDY; INCIDENCE; INTERMITTENT POSITIVE PRESSURE VENTILATION; LUNG DISEASE;

CHRONIC DISEASE; CYTOKINES; HIGH-FREQUENCY VENTILATION; HUMANS; INCIDENCE; INFANT; INTERMITTENT POSITIVE-PRESSURE VENTILATION; LUNG DISEASES;

EID: 33644694943     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Vento G, Matassa PG, Ameglio F, et al. HFOV in premature neonates: effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial. Intensive Care Med 2005; 31: 463.
2. Yoder BA, Siler-Khodr T, Winter VT, et al. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med 2000; 162: 1867.
3. von der Hardt K, Kandler MA, Fink L, et al. High frequency oscillatory ventilation suppresses inflammatory response in lung tissue and microdissected alveolar macrophages in surfactant depleted piglets. Pediatr Res 2004; 55: 339.
4. Thome U, Gotze-Speer B, Speer CP, et al. Comparison of pulmonary inflammatory mediators in preterm infants treated with intermittent positive pressure ventilation or high frequency oscillatory ventilation. Pediatr Res 1998; 44: 330.
5. Jankov RP, Tanswell K. Growth factors, postnatal lung growth and bronchopulmonary dysplasia. Paediatr Respir Rev 2004; 5: S265.
6. Vento G, Matassa PG, Ameglio F, et al. Effects of early dexamethasone on pulmonary fibrogenic mediators and respiratory mechanics in preterm infants. Eur Cytokine Netw 2002; 13: 207.
7. Vento G, Matassa PG, Capoluongo E, et al. Glucocorticoids in preterm infants and discrepancies of Vascular Endothelial Growth Factor. Am J Respir Crit Care Med 2003; 168: 501.
8. Gitto E, Reiter RJ, Amodio A, et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res 2004; 36: 250.
9. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33: 1.
10. Abman SH, Groothuis JR. Pathophysiology and treatment of bronchopulmonary dysplasia: current issues. Pediatr Clin North Am 1994; 41:277.
11. Ellsbury DL, Acarregui MJ, McGuinness GA, et al. Controversy surrounding the use of home oxygen for premature infants with bronchopulmonary dysplasia. J Perinatol 2004; 24: 36.
12. Ricard JD, Dreyfuss D, Saumon G. Ventilator-induced lung injury. Eur Respir J 2003; 42: 2S.
13. Bustani P, Kotecha S. Role of cytokines in hyperoxia mediated inflammation in the developing lung. Front Biosci 2003; 8: 694S.
14. Kumar VH, Ryan RM. Growth factors in the fetal and neonatal lung. Front Biosci 2004; 1: 464.
15. Laberge S, El Bassam S. Cytokines, structural cells of the lungs and airway inflammation. Paediatr Respir Rev 2004; 5: S41.
16. Tortorolo L, Vento G, Matassa PG, et al. Early changes of pulmonary mechanics to predict the severity of bronchopulmonary dysplasia in ventilated preterm infants. J Matern Fetal Neonatal Med 2002; 12: 332.
17. Niermeyer S, Kattwinkel J, Van Reempts P, et al. International Guidelines for Neonatal Resuscitation: An Excerpt From the Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Internal Consensus Sci Pediatr 2000; 106: 1.
18. Collard KJ, Godeck S, Holley JE, et al. Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. Arch Dis Child Fetal Neonatal 2004; 89: F412.
19. Pierce MR, Bancalari E. The role of inflammation on the pathogenesis of brunchopulmonary dysplasia. Ped Pulmonol 1995; 9: 371.
20. Bonifati C, Ameglio F. Cytokines in psoriasis. Int J Dermatol 1999; 38: 241.
21. d'Auria L, Cordiali-Fei P, Ameglio F. Cytokines and bullous pemphigoid. Eur Cytokine Netw 1999; 10: 123.